» Articles » PMID: 29234096

Transit and Integration of Extracellular Mitochondria in Human Heart Cells

Overview
Journal Sci Rep
Specialty Science
Date 2017 Dec 14
PMID 29234096
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue ischemia adversely affects the function of mitochondria, which results in impairment of oxidative phosphorylation and compromised recovery of the affected organ. The impact of ischemia on mitochondrial function has been extensively studied in the heart because of the morbidity and mortality associated with injury to this organ. As conventional methods to preserve cardiac cell viability and contractile function following ischemia are limited in their efficacy, we developed a unique approach to protect the heart by transplanting respiration-competent mitochondria to the injured region. Our previous animal experiments showed that transplantation of isolated mitochondria to ischemic heart tissue leads to decreases in cell death, increases in energy production, and improvements in contractile function. We also discovered that exogenously-derived mitochondria injected or perfused into ischemic hearts were rapidly internalised by cardiac cells. Here, we used three-dimensional super-resolution microscopy and transmission electron microscopy to determine the intracellular fate of endocytosed exogenous mitochondria in human iPS-derived cardiomyocytes and primary cardiac fibroblasts. We found isolated mitochondria are incorporated into cardiac cells within minutes and then transported to endosomes and lysosomes. The majority of exogenous mitochondria escape from these compartments and fuse with the endogenous mitochondrial network, while some of these organelles are degraded through hydrolysis.

Citing Articles

Mitochondrial Transplantation in Animal Models of Psychiatric Disorders: A Novel Approach to Psychiatric Treatment.

Iwata K, Noguchi M, Shintani N Biomolecules. 2025; 15(2).

PMID: 40001487 PMC: 11852835. DOI: 10.3390/biom15020184.


Mitochondria-Targeted Biomaterials-Regulating Macrophage Polarization Opens New Perspectives for Disease Treatment.

Tian Z, Wang X, Chen S, Guo Z, Di J, Xiang C Int J Nanomedicine. 2025; 20:1509-1528.

PMID: 39925677 PMC: 11806677. DOI: 10.2147/IJN.S505591.


Mitochondrial transplantation for the treatment of cardiac and noncardiac diseases: mechanisms, prospective, and challenges.

Wang X, Liu Z, Zhang L, Hu G, Tao L, Zhang F Life Med. 2025; 3(2):lnae017.

PMID: 39872662 PMC: 11749488. DOI: 10.1093/lifemedi/lnae017.


Mitochondrial dysfunction and Alzheimer's disease: pathogenesis of mitochondrial transfer.

Wei Y, Du X, Guo H, Han J, Liu M Front Aging Neurosci. 2025; 16:1517965.

PMID: 39741520 PMC: 11685155. DOI: 10.3389/fnagi.2024.1517965.


Targeting mitochondrial transfer: a new horizon in cardiovascular disease treatment.

Zuo B, Li X, Xu D, Zhao L, Yang Y, Luan Y J Transl Med. 2024; 22(1):1160.

PMID: 39741312 PMC: 11687156. DOI: 10.1186/s12967-024-05979-x.


References
1.
Robertson C, Tran D, George S . Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells. 2013; 31(5):829-37. PMC: 3749929. DOI: 10.1002/stem.1331. View

2.
Kumari S, Mg S, Mayor S . Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 2010; 20(3):256-75. PMC: 7091825. DOI: 10.1038/cr.2010.19. View

3.
Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C . Transfer of mitochondria from astrocytes to neurons after stroke. Nature. 2016; 535(7613):551-5. PMC: 4968589. DOI: 10.1038/nature18928. View

4.
Exner N, Lutz A, Haass C, Winklhofer K . Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 2012; 31(14):3038-62. PMC: 3400019. DOI: 10.1038/emboj.2012.170. View

5.
Singh B, Modica-Napolitano J, Singh K . Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome. Semin Cancer Biol. 2017; 47:1-17. PMC: 5681893. DOI: 10.1016/j.semcancer.2017.05.004. View